Posted by: admin Categories: Genetics

Samarth Kulkarni - Chief Executive Officer of CRISPR Therapeutics. David Altshuler - Vertex's Executive Vice President of Global Research and Chief ...

Source link

« Impact Of Covid 19 On Irreversible Electroporation Ablators Market 2020 Industry Challenges Business Overview And Forecast Research Study 2026

Top Ranked Value Stocks to Buy for December 9th »

Latest Tweets

BREATHING VR: Lately we are sourcing this VR headset for use in Breathing VR application. It allows easiest install… twitter.com/i/web/status/13990…
May 30, 2021 3:52 pm
Update: Each purchase of Breathing+ will now include three machine washable mouthpieces. Previous buyers will be su… twitter.com/i/web/status/13328…
November 28, 2020 10:41 pm
Update: We moved servers + relocated all our games to our servers, please be patient while google reviews all that… twitter.com/i/web/status/13237…
November 3, 2020 7:31 pm
Registration and all functionalities at breathinglabs.com (and in our iOS and Android games) are fixed and fu… twitter.com/i/web/status/12407…
March 19, 2020 10:50 pm
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys… twitter.com/i/web/status/11717…
September 11, 2019 12:00 pm
BREAKING: Nintendo Co. Ltd (Japan) is implementing Breathing Games by @breathinglabs in FDA approved clinical trial… twitter.com/i/web/status/11580…
August 4, 2019 5:55 pm
Notice to b2b partners: we are running late with some minor upgrade-> briefly running out of stock -> retail and b2… twitter.com/i/web/status/11337…
May 29, 2019 1:48 pm
BREAKING: Our product BREATHING+ shows significant and reliable diagnostic value in comparison to standard spiromet… twitter.com/i/web/status/10812…
January 4, 2019 4:02 pm
Video: Resperate company endorses pursed lip breathing and shows pulmonary function improvement in real time.… twitter.com/i/web/status/10711…
December 7, 2018 8:51 pm

Home

How To Start

Q&A

Login

CRISPR Therapeutics AG (CRSP) Phase 1/2 CTX001 Investor Update (Transcript)

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE

Home

How To Start

Products

Breathing+ Package

Toys Package

Q&A

Login

CRISPR Therapeutics AG (CRSP) Phase 1/2 CTX001 Investor Update (Transcript)

You may also like...

Where Will CRISPR Therapeutics Be in 5 Years?

Merlin haplotyping problem

Global Sickle Cell Disease Drug Market Insights Report 2019-2025 – Acceleron Pharma Inc …

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE